PERMANTIS

Diagnostics for clinical and scientific research purposes; diagnostic tools, diagnostic preparations, biologics and therapeutics for clinical and scientific research purposes, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic tests used for providing clinical scientific laboratory services according to the Clinical Laboratory Improvement Amendments (CLIA) program, namely, for the detection of diseases, disorders and conditions

Diagnostics, biologics and therapeutics for medical use, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic kits for medical use, namely, the detection of diseases, disorders and conditions; pharmaceutical preparations for medical use, namely, the detection, disruption, prevention and treatment of diseases, disorders and conditions; diagnostic tests used for providing medical testing services according to the Clinical Laboratory Improvement Amendments (CLIA) program, namely, for the detection of diseases, disorders and conditions

Promoting technical and scientific investigation, research and experimentation in the field of genomics; promoting technical and scientific investigation, research and experimentation in the field of patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of diseases, disorders and conditions

Financial asset and investment management services; financial services, namely, private equity investments and funding in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; investment services, namely, investing in technologies focused on the detection, disruption, prevention and treatment of diseases, disorders and conditions; financial services, namely, business fundraising for others; fundraising to support scientific and medical research and procedures; capital investment services

Biological and pharmaceutical research and development; medical and scientific research; scientific and medical research and consulting in the field of genomics; scientific and medical research and consulting focused on the detection, disruption, prevention and treatment of diseases, disorders and conditions; technical scientific research and medical research services focused on patient-specific nucleic acid sequencing and analysis for the detection, disruption, prevention and treatment of diseases, disorders and conditions; research, design, development and testing of diagnostics, biologics and therapeutics for the detection, disruption, prevention and treatment of diseases, disorders and conditions; providing laboratory research services in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; providing medical and scientific research information in the fields of genomics and the detection, disruption, prevention and treatment of diseases, disorders and conditions; compilation of biological and statistical data for research purposes in the fields of medical and scientific research; providing clinical scientific laboratory services for others according to the Clinical Laboratory Improvement Amendments (CLIA) program; CLIA-based medical testing for diagnostic purposes; providing nucleic acid sequencing and analysis services under CLIA certification standards; providing diagnostic services under CLIA certification standards, namely, collecting patient samples, processing and analyzing patient samples, and delivering results of the processing and analysis, all carried out in a CLIA-certified laboratory

Licensing of intellectual property rights